The UCSF Helen Diller Family Comprehensive Cancer Center brings experts from across cancer specialties within UCSF’s network and beyond to revolutionize how cancer is treated. UCSF Parker Institute investigators continue building on the university’s deep scientific expertise to advance research in T-cell therapies, CRISPR technology, the biology of the immune microenvironment and precision treatments. Kole Roybal, PhD | Director Julia Carnevale, MD | Co-Director All Investigators Related Press Release PICI, JDRF and Helmsley Trust Form Research Initiative Announcement PICI Young Investigator Retreat 2019 Announcement, Press Release PICI Network Shapes Future of Immunotherapy at AACR 202 Announcement, Press Release PICI and CVC Unite to Accelerate Cancer Vaccines Announcement, Press Release Parker Institute for Cancer Immunotherapy Appoints Bolyn Hubby as Chief of Staff to Strengthen Organization Excellence During Period of Growth Announcement, Press Release Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer Announcement, Press Release Parker Institute for Cancer Immunotherapy Collaborates with Conquer Cancer and ASCO to Support Promising Cancer Research Announcement Parker Institute for Cancer Immunotherapy Announces Appointment of Mark Veich as Chief Organizational Advancement Officer Announcement, Press Release Parker Institute for Cancer Immunotherapy Demonstrates Leadership and Showcases Latest Advances in Immunotherapy at SITC 2025 Annual Meeting
Announcement, Press Release Parker Institute for Cancer Immunotherapy Appoints Bolyn Hubby as Chief of Staff to Strengthen Organization Excellence During Period of Growth
Announcement, Press Release Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer
Announcement, Press Release Parker Institute for Cancer Immunotherapy Collaborates with Conquer Cancer and ASCO to Support Promising Cancer Research
Announcement Parker Institute for Cancer Immunotherapy Announces Appointment of Mark Veich as Chief Organizational Advancement Officer
Announcement, Press Release Parker Institute for Cancer Immunotherapy Demonstrates Leadership and Showcases Latest Advances in Immunotherapy at SITC 2025 Annual Meeting